Luye Life Sciences Unveils Cutting-edge Advances in Gene and Cell Therapy at ASGCT 2021
Share this article Share this article BOSTON, May 13, 2021 /PRNewswire/ -- The Boston R&D Center and GeneLeap Biotech, two subsidiaries of Luye Life Sciences Group, took part in the 24 th American Society of Gene & Cell Therapy (ASGCT) Annual Meeting, presenting the progress of four of the companys latest preclinical developments in gene and cell therapy to the global biological community. ASGCT is one of the worlds most influential academic conferences in the area of gene and cell therapy. ...
United States Sean Fu Jason Zhang Luye Life Sciences Indiana University School American Society Of Gene Cell Therapy
Source: prnewswire.com